Chung Shimin Jasmine, Tan Ek Khoon, Kee Terence, Krishnamoorthy Thinesh Lee, Phua Ghee Chee, Sewa Duu Wen, Ong Boon-Hean, Tan Teing Ee, Sivathasan Cumaraswamy, Gan Huei Li Valerie, Goh Brian Kim Poh, Jeyaraj Prema Raj, Tan Ban Hock
Department of Infectious Diseases, Singapore General Hospital, Singapore.
SingHealth Duke-NUS Transplant Centre, Singapore.
Transplant Direct. 2020 May 8;6(6):e554. doi: 10.1097/TXD.0000000000001002. eCollection 2020 Jun.
The current coronavirus disease 2019 (COVID-19) pandemic has not only caused global social disruptions but has also put tremendous strain on healthcare systems worldwide. With all attention and significant effort diverted to containing and managing the COVID-19 outbreak (and understandably so), essential medical services such as transplant services are likely to be affected. Closure of transplant programs in an outbreak caused by a highly transmissible novel pathogen may be inevitable owing to patient safety. Yet program closure is not without harm; patients on the transplant waitlist may die before the program reopens. By adopting a tiered approach based on outbreak disease alert levels, and having hospital guidelines based on the best available evidence, life-saving transplants can still be safely performed. We performed a lung transplant and a liver transplant successfully during the COVID-19 era. We present our guidelines and experience on managing the transplant service as well as the selection and management of donors and recipients. We also discuss clinical dilemmas in the management COVID-19 in the posttransplant recipient.
当前的2019冠状病毒病(COVID-19)大流行不仅造成了全球社会混乱,也给全球医疗系统带来了巨大压力。由于所有注意力和大量精力都转向了遏制和管理COVID-19疫情(这是可以理解的),诸如移植服务等基本医疗服务可能会受到影响。由于患者安全问题,在由高传播性新型病原体引发的疫情中关闭移植项目可能是不可避免的。然而,项目关闭并非没有危害;移植等待名单上的患者可能在项目重新开放之前死亡。通过基于疫情警报级别采取分层方法,并依据现有最佳证据制定医院指南,仍可安全地进行挽救生命的移植手术。在COVID-19时代,我们成功进行了一例肺移植和一例肝移植。我们介绍我们在管理移植服务以及供体和受体的选择与管理方面的指南和经验。我们还讨论了移植后受者中COVID-19管理方面的临床困境。